Related Experiment Videos

Diffuse cutaneous mastocytosis responding to cyproheptadine

U Enomoto1, H Kusakabe, T Matsumura

  • 1Department of Dermatology, Osaka Medical College, Osaka, Japan.

Insights

A rare infant skin condition presents with leathery skin and blisters. Cyproheptadine, an anti-serotonin drug, effectively reduced blistering in a case of congenital bullous dermatosis.

Area of Science:

  • Pediatric Dermatology
  • Dermatopathology
  • Mast Cell Biology

Background:

  • Congenital bullous dermatoses represent a group of rare blistering disorders presenting at birth.
  • Mastocytosis is characterized by abnormal mast cell proliferation, which can manifest in the skin.

Observation:

  • A 3-month-old infant presented with generalized, thickened, leathery skin and recurrent blisters since birth.
  • Blisters healed without scarring, and Darier's sign was positive.
  • Microscopic examination revealed a dense dermal infiltrate with mast cells and subepidermal bulla formation.

Findings:

  • The infant showed no signs of systemic mastocytosis.
  • Treatment with cyproheptadine, an antihistamine with anti-serotonin activity, significantly reduced blistering.
  • Histopathology confirmed features suggestive of a bullous dermatosis with mast cell infiltration.

Implications:

  • This case highlights a potential therapeutic option for congenital bullous dermatoses.
  • Cyproheptadine's efficacy suggests a role for serotonin pathways in the pathogenesis of these conditions.
  • Further research is warranted to explore anti-serotonergic agents in managing similar pediatric skin disorders.

Related Concept Videos